Peptides9 min read
Does KPV prevent cancer in people? The evidence gap behind the laboratory claims
A KPV study found benefits in one mouse model and no tumor reduction in another. Neither establishes cancer prevention in people.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Peptides articles
All articlesMetabolism, recovery and emerging research
Peptides9 min read
Do antibodies against cagrilintide necessarily mean treatment stops working?
Anti-drug antibodies were detected in cagrilintide research, but detection, neutralization and clinical loss of effect are different findings.
Read article
Peptides9 min read
Eloralintide and selective amylin agonism: what it means
Eloralintide's receptor preference is scientifically interesting. Human trials determine whether it translates into useful benefits.
Read article
Peptides8 min read
Does zenagamtide beat other weight-loss medicines? What the trials can tell us
Zenagamtide's early weight result is promising. Trial populations, duration, withdrawal and analysis explain why it cannot yet establish a ranking.
Read article
Peptides8 min read
Does ARA-290 pain improvement prove nerve regeneration?
Pain relief matters, but it cannot prove nerve regrowth. See what ARA-290 studies found in symptoms, corneal images, skin markers and function.
Read article
Peptides9 min read
What a longer kisspeptin treatment trial needs to show
Repeated kisspeptin studies help explain what comes next: sustained patient benefit, usable delivery, meaningful fertility outcomes and better safety follow-up.
Read article
Peptides9 min read
What longer zenagamtide trials need to tell patients
Longer zenagamtide studies are testing durable weight change, withdrawal and cardiovascular events. Each design answers a different patient question.
Read article
Peptides9 min read
Can an IGF-1 increase validate a CJC-1295 recomposition claim?
What an IGF-1 rise can tell you—and why CJC-1295 fat-loss and muscle claims need direct tissue and functional evidence.
Read article
Peptides8 min read
Sermorelin and body recomposition: what should be measured?
Body fat, lean tissue and strength are different outcomes. Explore direct sermorelin studies and what a scan can—and cannot—show about recomposition.
Read article
Peptides9 min read
GHRP-2 and appetite: what the human meal studies actually found
GHRP-2 increased food intake in small controlled human experiments. The longer studies tell a more limited story about weight, nutrition and muscle.
Read article
Peptides8 min read
Hexarelin and the heart: what the human studies actually measured
Small human studies found brief changes in heart pumping after hexarelin. Learn what those findings mean alongside mixed rodent results and unanswered clinical questions.
Read article
Peptides9 min read
Hexarelin desensitization: what repeated-response studies actually show
Hexarelin's repeated-response experiments show partial, reversible GH attenuation under some conditions. They do not establish an optimal cycle or lasting health benefit.
Read article217–228 of 323 articles